title: Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation.
abstract: Voriconazole is an established first-line agent for treatment of invasive fungal infections in patients undergoing allogeneic stem cell transplantation (ASCT). It is associated with the uncommon complication of periostitis. We report this complication in a 58-year-old female undergoing HSCT. She was treated with corticosteroids with minimal improvement. The symptoms related to periostitis can mimic chronic graft-versus-host disease in patients undergoing HSCT and clinicians should differentiate this from other diagnoses and promptly discontinue therapy.
authors.affiliation: Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL 60612, USA; Cancer Center, University of Illinois, Chicago, IL 60612, USA.
authors.forename: Karen
authors.identifier: 0000-0001-9559-0282
authors.initials: K
authors.lastname: Sweiss
authors.affiliation: Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL 60612, USA.
authors.forename: Annie
authors.initials: A
authors.lastname: Oh
authors.affiliation: Cancer Center, University of Illinois, Chicago, IL 60612, USA; Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL 60612, USA.
authors.forename: Damiano
authors.initials: D
authors.lastname: Rondelli
authors.affiliation: Cancer Center, University of Illinois, Chicago, IL 60612, USA; Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL 60612, USA.
authors.forename: Pritesh
authors.initials: P
authors.lastname: Patel